Episode Details
Back to Episodes
Cell and Gene Therapy Check-in 2024
Published 2 years, 4 months ago
Description
Fran Gregory, VP of Emerging Therapies, Cardinal Health discusses her career, how both CAR-T therapies and personalization have been gaining momentum and what kind of progress we expect to see from them, some of the biggest hurdles facing their section of the industry, the importance of patient advocacy and so much more.